AI

  • Wysa and April Health merge in primary care partnership

    April Health, a company integrating behavioural health into primary care, has announeced a merger with AI mental health company, Wysa. The collaboration aims to provide patients with continuous, personalised care, through a combination of behavioural health specialists, psychiatrists and Wysa’s AI-driven guidance. The combination of AI and human resources in one model of care will [...]

  • Exploring the opportunities and challenges of AI in the future of healthcare

    Artificial intelligence is revolutionising industries across the globe, and healthcare is no exception. From diagnostics and drug discovery to data analysis and patient monitoring and much more, AI is transforming how we approach healthcare. Health Tech World speaks to experts in the field to discover their thoughts on AI’s future in the sector, where it [...]

  • Oxipit appoints Dr Robert Epstein to Radiology Advisory Board

    Oxipit, a leading AI-driven healthcare technology company, has announced the appointment of Dr Robert Epstein to its Radiology Advisory Board. His expertise in radiology and healthcare strategy will support Oxipit’s mission to enhance diagnostic workflows worldwide through trusted AI solutions, enabling faster, more precise diagnoses and advancing patient care. Dr Epstein, a recognised leader in [...]

  • AI predicts lengths of hospital stays for people with learning disabilities

    A newly developed AI model can predict how long a person with a learning disability is likely to stay in hospital, offering insights to hep improve care and resource planning. The model aims to tackle healthcare challenges faced by people with learning disabilities and multiple health conditions. Developed by computer scientists at Loughborough University as [...]

  • AI significantly improves detection of brain abnormalities linked to epilepsy, study finds

    Scientists have developed an AI-powered tool that detects 64 per cent of brain abnormalities linked to epilepsy that human radiologists miss.  MELD Graph is an AI tool that could drastically change the care for 30,000 patients in the UK and 4 million worldwide with one cause of epilepsy, researchers say. The study shows how the [...]

  • ‘World’s first’ AI-powered cardiovascular retinal screening to be launched in the UK

    Heart Eye is set to unveil the world’s first AI-powered cardiovascular screening technology using retinal imaging, delivering patients’ cardiovascular disease risk results in just 3 minutes. Dr.Noon CVD, the groundbreaking product being launched in the UK by Dr Husain Khaki, will debut at two major optical conferences: 100% Optical at ExCeL London and the Optix [...]

  • AI investment aims to transform British cancer care and spark new drug breakthroughs

    The UK government has unveiled £82.6 million in new flexible forms of research funding, plus a new commitment to give UK researchers access to cutting-edge computing resources as part of a plan to unlock the power of AI.   Two of the three projects benefiting from this support will harness AI to develop treatments and diagnostics [...]

  • Introducing Nurse Avery – a Google-backed tool versus the healthcare shortfall

    Google’s public sector division has partnered with a digital health firm to launch a new AI-driven nurse. Google Public Sector’s advanced technology and cloud infrastructure helped US-based startup Drive Health to create Nurse Avery as a partnership project. Its capabilities include real-time chart reviews, appointment scheduling, and proactive engagement.  Drive Health said the development fits [...]

  • AI arms race heats up – but mistrust from UK health sector endures

    This week has seen an escalation of the one-upmanship that has defined the AI era as news of a new Chinese player hit global headlines. On Monday, US tech giant Nvidia lost over a sixth of its value following the launch of Chinese chatbot, DeepSeek. Firms connected to Nvidia, including Microsoft and Google, also saw [...]

  • TME Pharma collaborates with aimed analytics to advance AI-driven drug discovery

    TME Pharma N.V., a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer, has announced a collaboration with medical data analytics company, aimed analytics. The partnership aims to leverage AI to create new and improved drug candidates without the need for time and resource-intensive laboratory testing. The collaboration leverages recent advances in [...]